# Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.

> **NCT03529292** · NA · COMPLETED · sponsor: **Symbioken** · enrollment: 23 (actual)

## Conditions studied

- Skin Aging

## Interventions

- **DEVICE:** AmeaCell

## Key facts

- **NCT ID:** NCT03529292
- **Lead sponsor:** Symbioken
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03529292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03529292, "Pilot Study to Evaluate the Safety and the Efficacy of the Matrix and Cells Obtained by the AmeaCell® Device and Intended for the Filling of Wrinkles on the Face.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03529292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*